170 related articles for article (PubMed ID: 19116338)
1. Epidermal growth factor receptor pathway substrate 8 is overexpressed in human pituitary tumors: role in proliferation and survival.
Xu M; Shorts-Cary L; Knox AJ; Kleinsmidt-DeMasters B; Lillehei K; Wierman ME
Endocrinology; 2009 May; 150(5):2064-71. PubMed ID: 19116338
[TBL] [Abstract][Full Text] [Related]
2. Bone morphogenetic protein and retinoic acid-inducible neural specific protein-3 is expressed in gonadotrope cell pituitary adenomas and induces proliferation, migration, and invasion.
Shorts-Cary L; Xu M; Ertel J; Kleinschmidt-Demasters BK; Lillehei K; Matsuoka I; Nielsen-Preiss S; Wierman ME
Endocrinology; 2007 Mar; 148(3):967-75. PubMed ID: 17138656
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms for growth factor-induced pituitary tumor transforming gene-1 expression in pituitary folliculostellate TtT/GF cells.
Vlotides G; Cruz-Soto M; Rubinek T; Eigler T; Auernhammer CJ; Melmed S
Mol Endocrinol; 2006 Dec; 20(12):3321-35. PubMed ID: 16959877
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA miR-107 is overexpressed in pituitary adenomas and inhibits the expression of aryl hydrocarbon receptor-interacting protein in vitro.
Trivellin G; Butz H; Delhove J; Igreja S; Chahal HS; Zivkovic V; McKay T; Patócs A; Grossman AB; Korbonits M
Am J Physiol Endocrinol Metab; 2012 Sep; 303(6):E708-19. PubMed ID: 22811466
[TBL] [Abstract][Full Text] [Related]
5. Mammalian Ste20-like kinase 4 promotes pituitary cell proliferation and survival under hypoxia.
Xiong W; Knox AJ; Xu M; Kiseljak-Vassiliades K; Colgan SP; Brodsky KS; Kleinschmidt-Demasters BK; Lillehei KO; Wierman ME
Mol Endocrinol; 2015 Mar; 29(3):460-72. PubMed ID: 25650755
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor, its receptor KDR/Flk-1, and pituitary tumor transforming gene in pituitary tumors.
McCabe CJ; Boelaert K; Tannahill LA; Heaney AP; Stratford AL; Khaira JS; Hussain S; Sheppard MC; Franklyn JA; Gittoes NJ
J Clin Endocrinol Metab; 2002 Sep; 87(9):4238-44. PubMed ID: 12213878
[TBL] [Abstract][Full Text] [Related]
7. Eps8 promotes cellular growth of human malignant gliomas.
Ding X; Zhou F; Wang F; Yang Z; Zhou C; Zhou J; Zhang B; Yang J; Wang G; Wei Z; Hu X; Xiang S; Zhang J
Oncol Rep; 2013 Feb; 29(2):697-703. PubMed ID: 23229386
[TBL] [Abstract][Full Text] [Related]
8. Eps8 regulates cellular proliferation and migration of breast cancer.
Chen C; Liang Z; Huang W; Li X; Zhou F; Hu X; Han M; Ding X; Xiang S
Int J Oncol; 2015 Jan; 46(1):205-14. PubMed ID: 25333707
[TBL] [Abstract][Full Text] [Related]
9. Reprimo (RPRM) is a novel tumor suppressor in pituitary tumors and regulates survival, proliferation, and tumorigenicity.
Xu M; Knox AJ; Michaelis KA; Kiseljak-Vassiliades K; Kleinschmidt-DeMasters BK; Lillehei KO; Wierman ME
Endocrinology; 2012 Jul; 153(7):2963-73. PubMed ID: 22562171
[TBL] [Abstract][Full Text] [Related]
10. Cyclic adenosine 3'-5'-monophosphate (cAMP) exerts proliferative and anti-proliferative effects in pituitary cells of different types by activating both cAMP-dependent protein kinase A (PKA) and exchange proteins directly activated by cAMP (Epac).
Vitali E; Peverelli E; Giardino E; Locatelli M; Lasio GB; Beck-Peccoz P; Spada A; Lania AG; Mantovani G
Mol Cell Endocrinol; 2014 Mar; 383(1-2):193-202. PubMed ID: 24373949
[TBL] [Abstract][Full Text] [Related]
11. EPS8 upregulates FOXM1 expression, enhancing cell growth and motility.
Wang H; Teh MT; Ji Y; Patel V; Firouzabadian S; Patel AA; Gutkind JS; Yeudall WA
Carcinogenesis; 2010 Jun; 31(6):1132-41. PubMed ID: 20351091
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of Eps8 in oral squamous cell carcinoma promotes cell migration and invasion through integrin-dependent Rac1 activation.
Yap LF; Jenei V; Robinson CM; Moutasim K; Benn TM; Threadgold SP; Lopes V; Wei W; Thomas GJ; Paterson IC
Oncogene; 2009 Jul; 28(27):2524-34. PubMed ID: 19448673
[TBL] [Abstract][Full Text] [Related]
13. AIP gene and familial isolated pituitary adenomas.
Ozfirat Z; Korbonits M
Mol Cell Endocrinol; 2010 Sep; 326(1-2):71-9. PubMed ID: 20457215
[TBL] [Abstract][Full Text] [Related]
14. Isolation and characterization of a novel pituitary tumor apoptosis gene.
Bahar A; Simpson DJ; Cutty SJ; Bicknell JE; Hoban PR; Holley S; Mourtada-Maarabouni M; Williams GT; Clayton RN; Farrell WE
Mol Endocrinol; 2004 Jul; 18(7):1827-39. PubMed ID: 15105437
[TBL] [Abstract][Full Text] [Related]
15. The role of proto-oncogene GLI1 in pituitary adenoma formation and cell survival regulation.
Lampichler K; Ferrer P; Vila G; Lutz MI; Wolf F; Knosp E; Wagner L; Luger A; Baumgartner-Parzer S
Endocr Relat Cancer; 2015 Oct; 22(5):793-803. PubMed ID: 26219678
[TBL] [Abstract][Full Text] [Related]
16. The interplay between Eps8 and IRSp53 contributes to Src-mediated transformation.
Liu PS; Jong TH; Maa MC; Leu TH
Oncogene; 2010 Jul; 29(27):3977-89. PubMed ID: 20418908
[TBL] [Abstract][Full Text] [Related]
17. Activation of RAF/MEK/ERK and PI3K/AKT/mTOR pathways in pituitary adenomas and their effects on downstream effectors.
Dworakowska D; Wlodek E; Leontiou CA; Igreja S; Cakir M; Teng M; Prodromou N; Góth MI; Grozinsky-Glasberg S; Gueorguiev M; Kola B; Korbonits M; Grossman AB
Endocr Relat Cancer; 2009 Dec; 16(4):1329-38. PubMed ID: 19620247
[TBL] [Abstract][Full Text] [Related]
18. In1-ghrelin splicing variant is overexpressed in pituitary adenomas and increases their aggressive features.
Ibáñez-Costa A; Gahete MD; Rivero-Cortés E; Rincón-Fernández D; Nelson R; Beltrán M; de la Riva A; Japón MA; Venegas-Moreno E; Gálvez MÁ; García-Arnés JA; Soto-Moreno A; Morgan J; Tsomaia N; Culler MD; Dieguez C; Castaño JP; Luque RM
Sci Rep; 2015 Mar; 5():8714. PubMed ID: 25737012
[TBL] [Abstract][Full Text] [Related]
19. Characterization of SNARE proteins in human pituitary adenomas: targeted secretion inhibitors as a new strategy for the treatment of acromegaly?
Garcia EA; Trivellin G; Aflorei ED; Powell M; Grieve J; Alusi G; Pobereskin L; Shariati B; Cudlip S; Roncaroli F; Mendoza N; Grossman AB; Harper EA; Korbonits M
J Clin Endocrinol Metab; 2013 Dec; 98(12):E1918-26. PubMed ID: 24152687
[TBL] [Abstract][Full Text] [Related]
20. Expression of epidermal growth factor receptor in neoplastic pituitary cells: evidence for a role in corticotropinoma cells.
Theodoropoulou M; Arzberger T; Gruebler Y; Jaffrain-Rea ML; Schlegel J; Schaaf L; Petrangeli E; Losa M; Stalla GK; Pagotto U
J Endocrinol; 2004 Nov; 183(2):385-94. PubMed ID: 15531726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]